Global Gene Synthesis Software Market – Industry Trends and Forecast to 2030

Análisis y tamaño del mercado de software de síntesis genética

Se ha observado que las políticas gubernamentales de apoyo relacionadas con la biología sintética son los principales factores impulsores del mercado. Las comunidades científicas están descubriendo vías sin explotar en este campo, lo que conduce al crecimiento de los ingresos. Los métodos tradicionales de clonación y mutagénesis están siendo sustituidos rápidamente por la síntesis de genes de novo, que también permite la producción de ácidos nucleicos.

Data Bridge Market Research analiza que se espera que el mercado de software de síntesis genética alcance los 5.750 millones de dólares en 2030, es decir, 1.470 millones de dólares en 2022, y se espera que experimente una CAGR del 18,6% durante el período de pronóstico de 2022 a 2030. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de la cartera de productos, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de software de síntesis genética

Definición de mercado

La síntesis genética es el proceso de generar genes artificiales en un laboratorio con la ayuda de la biología sintética. La generación de proteínas recombinantes es una de las diversas aplicaciones de la tecnología del ADN recombinante, en la que la síntesis genética se está convirtiendo en un instrumento importante.

Dinámica del mercado del software de síntesis genética

Conductores

• Demanda creciente de síntesis en fase sólida

La síntesis en fase sólida ha cobrado mucha importancia en los últimos años. La alta precisión de este método aumenta su aceptación entre los desarrolladores de terapias y los entornos de investigación. Aunque su alto coste y su bajo rendimiento dificultan su uso en algunos casos, están creando muchas oportunidades para otros métodos. Se prevé que los métodos basados ​​en PCR y otros chips muestren importantes CAGR durante el período de pronóstico. Estos métodos permiten la síntesis de fragmentos más grandes a una tasa mucho menor, lo que conduce a un mayor uso. Además, el método basado en PCR ofrece una alta precisión de la secuencia genética utilizando sistemas celulares.

• Alto uso de la medicina personalizada

La creciente demanda de medicamentos personalizados ha dado paso a la genómica, que exige secuencias genéticas libres de errores a un coste mucho más bajo y en un periodo muy corto, lo que actúa como una oportunidad para el mercado de síntesis genética. 

Oportunidades

• Aumento de la investigación clínica y del avance tecnológico

Los diversos avances en la tecnología del ADN sintético están atrayendo mucha atención como una medida factible para abordar los problemas asociados con el creciente número de patógenos en desarrollo y las amenazas de la próxima pandemia mundial. Esta estrategia resultó útil para responder rápidamente a la pandemia del SARS-CoV-2 junto con las pandemias futuras cercanas que involucran otros patógenos nuevos. Por lo tanto, esto impulsa el crecimiento del mercado. En las últimas décadas, la terapia dirigida es muy utilizada por los investigadores, así como por las empresas biotecnológicas y farmacéuticas. Se ha desarrollado como una forma importante de manejo de enfermedades. Se anticipa que esta terapia, junto con la quimioterapia y la inmunoterapia, experimentará un crecimiento importante en el futuro cercano, lo que, a su vez, está creando muchas oportunidades para los actores en desarrollo en el mercado.

Restricciones/Desafíos

• Enorme coste de las pruebas diagnósticas

Several tests are widely available for testing cardiovascular, chronic diseases, and other conditions such as diabetes. But these tests are of heavy cost which many patients can't afford, particularly those belonging to the lower economic groups. Therefore, it hampers the market growth.

• Lack of skilled professionals

A scarcity of skilled professionals in the field of gene synthesis and biotechnology is a major obstacle for the market growth, as the key market players require trained and experienced staff at their facilities. Therefore, several companies are now partnering with numerous universities and offering on-site training, online workshops, and sponsored projects to hugely develop the right professionals, thus boosting the market growth

This gene synthesis software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Gene Synthesis Software Market

The COVID-19 pandemic has benefited the market, with respect to new growth opportunities. Several scientific communities are discovering untapped avenues in the space, thus leading to higher revenue growth. For instance, researchers at the National Institute of Standards and Technology (NIST) have developed synthetic gene fragments from the COVID-19 virus to help different  diagnostic developers to launch more accurate and reliable diagnostic tests for the disease

Recent Developments

In 2020, Twist Bioscience launched clonal-ready gene fragments in order to complete the offering of genes. These fragments can be used with or without adapters to build up the perfect clones. The clonal-ready gene fragments are compatible with the enzyme engineering, and gene expression, protein expression pathways, among others.

Global Gene Synthesis Software Market Scope

The gene synthesis software market is segmented on the basis of applications, synthesis type, method, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Research and Development Activities
• Diagnostics
• Therapeutics
• Others

Synthesis Type

• Gene Library Synthesis
• Custom Gene Synthesis

Method

• Solid Phase Synthesis
• Chip-Based DNA Synthesis
• PCR-Based Enzyme Synthesis

End-user

• Hospital and Clinics
• Diagnostic Laboratories
• Others

Gene Synthesis Software Regional Analysis/Insights

The gene synthesis software market is analyzed and market size insights and trends are provided by applications, synthesis type, method and end-user as referenced above.

The countries covered in the gene synthesis software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the gene synthesis software market due to the growing demand from the academic institutes and biopharmaceutical companies with occurrence of numerous market players in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing levels of investment for synthetic biology and the incidence of private companies in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The gene synthesis software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gene synthesis software market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gene synthesis software market. The data is available for historic period 2011-2020.

Competitive Landscape and Global Gene Synthesis Software Market Share Analysis

The gene synthesis software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gene synthesis software market.

Some of the major players operating in the gene synthesis software market are:

• GenScript (China)
• Sangamo Therapeutics (U.S.)
• Eurofins Genomics (Japan)
• ATDBio Ltd (U.S.)
• BIONEER CORPORATION. (South Korea)
• Kaneka Eurogentec S.A. (Belgium)
• GENEWIZ Germany GmbH (Germany)
• Twist Bioscience (U.S.)
• Synthetic Genomics (U.S.)
• Codexis Inc. (U.S.)
•  Synthego (U.S.)
• Creative Enzymes (U.S.)
• Eurofins Scientific (Luxembourg)
• Cyrus Biotechnology Inc. (U.S.)
• ATUM (U.S.)
• TeselaGen (U.S.)
• Arzeda (U.S.)
• Integrated DNA Technologies Inc. (U.S.)
• New England Biolabs (U.S.)
• Genome Medical, Inc. (U.S.)
• BioMed Central Ltd (U.K.)

SKU-57117